Plasma derived and recombinant factor VIII concentrates induce a different rate of inhibitor development in hemophilia A patients. A systematic review of the literature - Iorio,A.; Marucci,M.; Mareschesisni,P.; Manucci,M. (J Thromb Haemost, 2009)